...the revocation of licenses. [42 FR 4718, Jan. 25, 1977, as amended at 61 FR 24233, May 14, 1996; 64 FR 56452, Oct. 20, 1999] §601.25 Review procedures...products from the provisions of the Federal Food, Drug, and Cosmetic Act is superseded to the extent that these regulations result in imposing requirements...

...601.8 with respect to the suspension and the revocation of licenses. [42 PR 4718, Jan. 25, 1977] § 601.25 Review procedures to determine that licensed...products from the provisions of the Federal Food, Drug, and Cosmetic Act is superseded to the extent that these regulations result in imposing requirements...

...FR 4718, Jan. 25, 1977, as amended at 61 FR 24233, May 14, 1996; 64 FR 56452, Oct. 20, 1999] $601.25 Review procedures to determine that licensed biological...products from the provisions of the Federal Food, Drug, and Cosmetic Act is superseded to the extent that these regulations result in imposing requirements...

...development. 601.22 Products in short supply; initial manufacturing at other than licensed establishment. 601.25 Review procedures to determine that licensed...prescribed, recommended, or suggested conditions of use. 601.26 Reclassification procedures to determine that licensed biological products are safe, effective,...

...601.8 with respect to the suspension and the revocation of licenses. [42 FB 4718, Jan. 25, 1977] § 601.25 Review procedures to determine that licensed...misbranded under prescribed, recommended, or suggested condition* of use. For purposes of reviewing biological products that have been licensed prior to July...

...601.40, 601.42, and 601.43 with respect to the summary suspension and the revocation of licenses. § 601.25 Review procedures to determine that licensed...safe, effective, and not misbranded under prescribed^ _recommended, or suggested condition* of use. For purposes of reviewing biological products that have...

...development. 601.22 Products in short supply; initial manufacturing at other than licensed establishment. 601.25 Review procedures to determine that licensed biological products are safe, effective, and not mlsbranded under prescribed, recommended, or suggested conditions of use. 601.26 Reclassification procedures...

...procedures for rule making for the classification of OTC drugs as generally recognized as safe and effective and not misbranded under prescribed, recommended, or suggested conditions of use. For purposes of classifying over-the-counter (OTC) drugs as drugs generally recognized among qualified experts as safe...

...273.234, and 273.235 with respect to the summary suspension and the revocation of licenses. § 273.245 Review procedures to determine that licensed biological...products from the provisions of the Federal Food, Drug, and Cosmetic Act is superseded to the extent that these regulations result in imposing requirements...

...procedures for classifying some OTC drugs as generally recognized among qualified experts as safe and effective and not misbranded under prescribed, recommended, or suggested conditions of use. Any OTC drug not conforming to the requirements established for such drugs must be the subject of an...